PATENT CLAIM ANALYSIS

Application Number: 15924511
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["424", "186100"]

Abstract:
The invention relates to a truncated L1 protein of the Human Papillomavirus Type 11, a virus-like particle consisting of the protein, a vaccine comprising said virus-like particle, and the use of the vaccine in the prevention of condyloma acuminatum or HPV infections.

Claim (Index 26):
A method of claim  12  comprising blending the VLP according to  claim 19 , and one or more VLPs selected from the group consisting of VLPs of HPV types 6, 16, 18, 31, 33, 45, 52, and 58, with carriers or excipients useful for vaccines.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 90.0
- Lexical Diversity: 1.48387
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15350264', '12601972', '14248063', '12601983', '12598187']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8488304015614831
- 35 USC 102 Novelty (BERT): 0.7132803128097408
- Combined Prediction Score: 0.8352753926863089
- Mean Citation Score: 748.287266
- Max Citation Score: 797.6519
- Similarity Product: 764.3260076344966

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test